Evaluation of planar scintimammography with 99mTc-MIBI in the detection of axillary lymph node metastases of breast carcinoma

Acta Radiologica

Volumn 40, Issue 5, 1999, Pages 491-495

  Danielsson, Rimma ^a   Bone B ^a   Perbeck, L ^a   Aspelin, P ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Breast neoplasms, axillary lymph nodes; Radionuclide studies

Indexed keywords

DIAGNOSTIC AGENT; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; RADIOPHARMACEUTICAL AGENT;

ARTICLE; AXILLA; BREAST TUMOR; CARCINOMA IN SITU; COMPARATIVE STUDY; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; LYMPH NODE; LYMPH NODE METASTASIS; PATHOLOGY; PROSPECTIVE STUDY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY;

AXILLA; BREAST NEOPLASMS; CARCINOMA IN SITU; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC ERRORS; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M SESTAMIBI;

EID: 0033194885     PISSN: 02841851     EISSN: None     Source Type: Journal    
DOI: 10.3109/02841859909175573     Document Type: Review

References (15)

1. CADY B.: Is axillary lymph node dissection necessary in routine management of breast carcinoma? No. The Breast J. 3 (1997), 246.
2. CLAYTON F. & HOPKINS C. L.: Pathologic correlates of prognosis in lymph node-positive breast carcinomas. Cancer 71 (1993), 1780.
3. 99mTc-sestamibi in the diagnosis of breast carcinoma Acta Radiol. 40 (1999), 176.
4. DONEGAN W. L., STINE S. B. & SAMTER T. G.: Implications of extracapsular nodal metastases for treatment and prognosis of breast cancer. Cancer 71 (1993), 778.
5. FRISELL J., GLAS U., HELLSTRÖM L. & SOMELL A.: Randomized mammographic screening for breast cancer in Stockholm. Design, first round results and comparisons. Breast Cancer Res. Treat. 8 (1986), 45.
6. JONSSON C., FARNEBO L.-O., FERNSTRÖM A. & JACOBSSON H.: Sweat glands accumulate Tc-99m MIBI. Clin. Nucl. Med. 21 (1996), 612.
7. KHALKHALI I.: New horizons in breast imaging. A complementary role of technetium 99m sestamibi for the diagnosis and staging of breast carcinoma. The Breast J. 2 (1996), 23.
8. LAM W. W. M., YANG W. T., CHAN Y. L., STEWART I. E. T., METREWELI C. & KING W.: Detection of axillary lymph node metastases in breast carcinoma by technetium-99m sestamibi breast scintigraphy, ultrasound and conventional mammography. Eur. J. Nucl. Med. 23 (1996), 498.
9. PALMEDO H., SCHOMBURG A., GRUNDWALD F., MALLMANN P., KREBS D. & BIERSACK H.-J.: Technetium-99m-MIBI scintimammography for suspicious breast lesions. J. Nucl. Med. 37 (1996), 626.
10. TABAR L., FAGERBERG G., DUFFY S. W., DAY N. E., GAD A. & GRÖNTOFT O.: Update of the Swedish two-country program of mammographic screening for breast cancer. Radiol. Clin. North Am. 30 (1992), 187.
11. TAILLEFER R., ROBIDOUX A., TURPIN S., LAMBERT R., CANTIN J. & LEVILLE J.: Metastatic axillary lymph node technetium-99m-MIBI imaging in primary breast cancer. J. Nucl. Med. 39 (1998), 459.
12. TAVASSOLI F. A.: Pathology of the breast. Appleton & Lange, 1992.
13. THURFJELL E.: Mammography screening methods and diagnostic results. Acta Radiol. 36 (1995), Suppl. 395, p. 22.
14. TOWNSEND C. M.: Treatment of breast cancer. Clin. Symp. 49 (1997), 3.
15. WILKING N., RUTQVIST L. E., CARSTENSEN J., MATSSON A. & SKOOG L.: Prognostic significance of axillary nodal status in primary breast cancer in relation to the number of resected nodes. Acta Oncol. 31 (1992), 29.